The effectiveness of a verbal opt-out system for human immunodeficiency virus screening during pregnancy

Obstetrics and Gynecology
Peter BreeseDebra Guinn

Abstract

We sought to evaluate the use of human immunodeficiency virus (HIV) screening during pregnancy in a health care system using the verbal opt-out method, in which HIV screening was recommended during all pregnancies and women were given an opportunity to refuse testing. This was a retrospective cohort study of pregnancies resulting in delivery from 1998 through 2001 at Denver Health Medical Center, an urban public hospital. The main outcome measure was the proportion of documented HIV screening within 9 months before the delivery date. Of 12,221 pregnancies resulting in delivery, HIV screening was completed in 12,000 (98.2%, 95% confidence interval 97.9-98.4%). Of the 221 women not screened for HIV, only 24 (10.9% of those not screened, 0.2% of all women in the study) were documented as refusing HIV testing. Patients not screened for HIV presented late in pregnancy, a median of 1 day before delivery, compared with a median of 176 days for those who were screened (P <.001). A verbal opt-out system was very effective in promoting HIV screening during pregnancy. Late presentation in pregnancy was associated with not having HIV screening performed.

References

Jun 12, 1998·JAMA : the Journal of the American Medical Association·H Minkoff, M J O'Sullivan
Aug 18, 1999·JAMA : the Journal of the American Medical Association·M L LindegrenP L Fleming
Jul 6, 2000·Journal of Acquired Immune Deficiency Syndromes : JAIDS·E R CooperR Hoff
Aug 14, 2001·American Journal of Public Health·A LanskyM L Lindegren

❮ Previous
Next ❯

Citations

Oct 31, 2007·Maternal and Child Health Journal·Mayris P WebberMarc Bulterys
Dec 25, 2007·AIDS Patient Care and STDs·Michael Jay WaxmanE Jane Carter
Mar 11, 2005·Current Opinion in Obstetrics & Gynecology·Jack Moodley, Jens L Wennberg
Aug 21, 2008·Obstetrical & Gynecological Survey·Victoria H ColemanJay Schulkin
Dec 3, 2014·Obstetrics and Gynecology Clinics of North America·Meghan Donnelly, Jill K Davies
Jun 28, 2011·Annals of Emergency Medicine·Douglas A E WhiteJames D Heffelfinger
Apr 28, 2007·Seminars in Perinatology·Elijah Paintsil, Warren A Andiman
Jan 8, 2010·Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine·Arin E FreemanJames A Wilde
Oct 23, 2009·American Journal of Obstetrics and Gynecology·Christopher V AlmarioJason K Baxter
Dec 18, 2013·Journal of Public Health Management and Practice : JPHMP·Caitlin NaureckasAdrian Gardner
Apr 26, 2011·International Journal of STD & AIDS·M R KennedyH C Wiesenfeld
May 6, 2015·International Journal of STD & AIDS·Stephen A BellJohn de Wit
Mar 21, 2018·Population Health Metrics·Charbel El BcheraouiAli H Mokdad
Mar 2, 2006·The Journal of Perinatal & Neonatal Nursing·Jan M Kriebs
Oct 10, 2019·Euro Surveillance : Bulletin Européen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin·Thi-Chiên TranFlorence Lot
May 13, 2011·The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics·Matthew W PierceSarah C Wyckoff

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.